Report of foreign issuer [Rules 13a-16 and 15d-16]

Condensed Interim Consolidated Statements of Changes in Shareholders??? Equity (Unaudited)

v3.25.3
Condensed Interim Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Ordinary Shares
Additional paid-in capital
Accumulated Shareholders’
Total
Balance at Dec. 31, 2023 $ 245,733 $ (203,640) $ 42,093
Balance (in Shares) at Dec. 31, 2023 77,925,095      
Stock-based compensation 12,038 12,038
Exercise of options 204 204
Exercise of options (in Shares) 3,184,800      
Net loss (37,121) (37,121)
Balance at Sep. 30, 2024 257,975 (240,761) 17,214
Balance (in Shares) at Sep. 30, 2024 81,109,895      
Balance at Dec. 31, 2024 275,453 (252,957) 22,496
Balance (in Shares) at Dec. 31, 2024 85,749,331      
Issuance of ordinary shares and warrants, net of issuance costs 30,758 30,758
Issuance of ordinary shares and warrants, net of issuance costs (in Shares) 10,332,031      
Conversion of convertible bonds 21,837 21,837
Conversion of convertible bonds (in Shares) 8,233,177      
Stock-based compensation 8,093 8,093
Exercise of options 440 440
Exercise of options (in Shares) 4,202,281      
Exercise of warrants 493 493
Exercise of warrants (in Shares) 342,682      
Net loss (35,011) (35,011)
Balance at Sep. 30, 2025 $ 337,074 $ (287,968) $ 49,106
Balance (in Shares) at Sep. 30, 2025 108,859,502